Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal primary angiosarcoma.

B Carnero López1, I Fernández Pérez, J A Carrasco Alvarez

  • 1Servicio de Oncología Médica, Hospital Xeral - Vigo, Complexo Hospitalario Universitario de Vigo, Vigo, Spain. beatrizcarnero@hotmail.com

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|December 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
Same author

Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
Same author

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2016
Same author

Update on adjuvant hormonal treatment of early breast cancer.

Advances in therapy·2011
Same author

Disseminated classic Kaposi's sarcoma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2007
Same author

[Up-date in the treatment of rapid cycling and other refractory bipolar disorders].

Actas espanolas de psiquiatria·2003
Same journal

Clinical and pathologic insights into early and late breast cancer relapses: a real-world analysis from the El Álamo IV registry.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Neoadjuvant metformin on clinical and pathological response in non-diabetic patients with non-metastatic breast cancer: an updated systematic review and meta-analysis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Comparative effectiveness of two alternative dosing strategies of pembrolizumab in metastatic non-small-cell lung cancer in a real-world setting.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Correction: Post-recurrence management of malignant glial brain tumors: therapeutic strategies, evidence and limitations, palliative care, terminal sedation, and end-of-life considerations.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

The importance of social vulnerability and exclusion in cancer prognosis and survival: a scoping review.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same journal

Challenges of tuberculosis in cancer patients: insights from two hospitals in Madrid.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
See all related articles

Primary renal angiosarcomas are rare cancers. This case highlights a middle-aged female with metastatic disease and poor prognosis despite aggressive treatment.

Area of Science:

  • Oncology
  • Pathology
  • Medical Research

Background:

  • Angiosarcomas are rare malignant vascular tumors.
  • Primary renal angiosarcomas constitute a very small subset of soft tissue sarcomas.
  • Literature review indicates limited documented cases of primary renal angiosarcomas.

Observation:

  • This report details the second documented case of primary renal angiosarcoma in a middle-aged female.
  • The patient presented with pulmonary metastases at the time of diagnosis.
  • The tumor's aggressive nature led to a fatal outcome.

Findings:

  • Primary renal angiosarcoma is an exceptionally rare malignancy.
  • Metastatic disease at diagnosis significantly impacts prognosis.
  • Standard treatment modalities (surgery and chemotherapy) were insufficient in this advanced case.

Related Experiment Videos

Implications:

  • Further research is needed to understand the biology and behavior of primary renal angiosarcomas.
  • Improved diagnostic and therapeutic strategies may be required for this aggressive cancer.
  • This case underscores the challenges in managing rare and advanced-stage sarcomas.